Company intelligence / Profile preview

Tsingke

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Tsingke is a leading synthetic biology company specializing in DNA and RNA synthesis, oligonucleotide production, and recombinant protein/antibody services. The company provides high-throughput, automated, and GMP-compliant manufacturing for research, diagnostics, and drug development applications. It serves global academic, biotech, and pharmaceutical clients, supporting innovation from discovery to industrialization. Tsingke hosts industry events and actively collaborates with major research institutions worldwide[1][2][3].

Modalities: Synthetic oligonucleotideGene therapyRNA therapyAntisense oligonucleotidesiRNAsgRNAGuide RNAAptamerRecombinant proteinAntibodyRecombinant antibody
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Tsingke.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tsingke.

Explore the full profile